Brief exposure to preoperative bevacizumab reveals a TGF-β signature predictive of response in HER-2 negative breast cancers | Case School of Engineering

Monday, February 1, 2016 - 12:00 PM

Anant Madabhushi

2016

International Journal of Cancer

138

3

10

School - Big Data and Digital Solutions

School - Human Health